Abstract Basal cells (BC) are the stem/progenitor cells of the human airway epithelium capable of differentiating into secretory and ciliated cells. Notch signaling activation increases BC differentiation into secretory cells, but the role of individual Notch ligands in regulating this process in the human airway epithelium is largely unknown. The objective of this study was to define the role of the Notch ligand JAG1 in regulating human BC differentiation. JAG1 over-expression in BC increased secretory cell differentiation, with no effect on ciliated cell differentiation. Conversely, knockdown of JAG1 decreased expression of secretory cell genes. These data demonstrate JAG1-mediated Notch signaling regulates differentiation of BC into secretory cells.
Introduction
The human airway epithelium, a complex tissue composed of basal, ciliated and secretory cells, provides barrier defense and protection against pathogens and inhaled particulates [1] [2] [3] . Basal cells (BC) are located throughout the conducting airways and function as the stem/progenitor population of the human airway epithelium capable of differentiating into the other specialized epithelial cell types during turnover and repair [4] [5] [6] [7] [8] [9] [10] [11] . This is in contrast to the murine airway epithelium whereby BC are restricted to the trachea and absent from more distal regions where other cell types function as stem/progenitors [8, 10] . The Notch signaling pathway regulates a wide variety of cellular processes, including stem cell renewal and differentiation [12] [13] [14] [15] . Activation of the Notch signaling cascade is a multi-step process involving binding of one of five plasma membrane bound Notch ligands (DLL1, DLL3, DLL4, JAG1 and JAG2) to one of four Notch receptors (NOTCH1-4) on the plasma membrane of a neighboring cell. Upon ligand binding, the receptor is cleaved at the intracellular transmembrane region, resulting in release of the Notch intracellular domain (NICD) which translocates to the nucleus and, in conjunction with RBPJ, functions as a transcriptional regulator of multiple target genes [16] [17] [18] . Murine studies have demonstrated that during development and in the adult lung, Notch signaling regulates differentiation of the airway epithelium into the secretory, Clara (also known as club cells), ciliated and neuroendocrine cell types [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] . In addition, there is increasing evidence that Notch signaling plays a central role in regulating the stem/progenitor capacity of both human and murine BC to differentiate into specific cell types, with specific Notch receptor activity regulating the balance of secretory and ciliated cell differentiation [24, 27-30, 32, 38, 39] .
The present study was designed to understand the role of individual Notch ligands in regulating human BC differentiation into a mucociliated epithelium. The data demonstrate that JAG1 expression is high in human BC and that modulation of its expression levels during differentiation of BC plays an important role in regulating secretory cell differentiation with no effect on ciliated cell differentiation. These observations have implications for developing novel targets to specifically modulate levels of secretory cells in human airway disorders.
Methods

Sampling the Airway Epithelium and Isolation of Primary Human Airway Basal Cells
Using Institutional Review Board-approved clinical protocols and after obtaining written informed consent, flexible bronchoscopy was performed to collect large airway epithelial cells by brushing the epithelium of healthy nonsmokers [5] . Pure populations of basal cells (BC) were obtained and characterized as previously described [5] . Both primary and immortalized (BCi-NS1.1 cells) BC were maintained in Bronchial Epithelial Growth Media (BEGM, Lonza, Walkersville, MD) and passaged by seeding at a cell density of 3000 cells/cm 2 in BEGM [40] .
RNA Sequencing Gene Expression
Nonsmoker primary BC (n = 5, at passage 0) and BCi-NS1.1 cells (n = 3) were assessed using RNA sequencing on the Illumina HiSeq2500 following TruSeq v2 mRNA library prep. The raw data are publically available at the Gene Expression Omnibus (GEO) site (http://www.ncbi.nlm.nih. gov/geo/), accession number GSE76421. Paired-end reads were processed with STAR (version 2.3.1z13_r470) [41] for alignment to the GRCh37/hg19 human reference genome and RefSeq gene definitions (2014-06-02). Gene expression quantification was performed using Cufflinks (version 2.2) with conversion of aligned reads into fragments per kilobase of exon per million fragments sequenced (FPKM) using the same RefSeq gene definitions to correct for transcript length and coverage depth. The expression level of Notch ligands was assessed with expression characterized as FPKM ≥0.04 in every sample.
Western Analysis
Western analysis was performed using NuPAGE 4 to 12 % Bis-Tris gradient gels (Invitrogen, Carlsbad, CA) [40] . The primary antibodies used were JAG1 (1/2000, SC-6011) and GAPDH (1/5000, SC-32233; both from Santa Cruz Biotechnology, Santa Cruz, CA).
TaqMan PCR
The expression of specific genes was assessed using TaqMan quantitative PCR and relative expression levels determined using the dCt method with 18S ribosomal RNA (Cat. No: 4308329, ThermoFisher Scientific, Waltham, MA) as the endogenous control [39] . Premade gene assays were obtained from ThermoFisher Scientific: JAG1 (Hs01070032_m1); HES1 (Hs00172878_m1); HES2 (Hs01021800_g1); HES4 (Hs00368353_g1); HES5 (Hs01387463_g1); HES6 (Hs00936587_g1); HEY1 (Hs01114113_m1); HEY2 (Hs00232622_m1); HEYL (Hs00232718_m1); KRT5 (Hs00361185_m1); TP63 (Hs00978343_m1); MUC5AC (Hs01365616_m1); SCGB1A1 (Hs00171092_m1); DNAI1 (Hs00201755_m1); and TEKT1 (Hs00364985_m1).
Air-Liquid Interface Culture
To investigate the differentiation of BC, primary (passage 1) and immortalized BC were grown on air-liquid interface (ALI) cultures [40] . For histological analysis ALI day 28 trans-well inserts were fixed for paraffin embedding and sectioning (performed by Histoserv, Germantown, MD). For general histology, sections were stained using standard protocols for hematoxylin and eosin (H&E) or Alcian blue [39] . For quantification of differentiation at the histological level via Alcian blue or immunofluorescence staining using cell type specific antibodies, a minimum of 10 images equally distributed between both ends of the sectioned membrane were acquired and a minimum of 500 total cells counted for each individual experiment.
Immunofluorescence
Immunofluorescence staining was performed on paraffin embedded cross-sections or direct top-staining of the ALI membrane [39] . The following primary antibodies were used: JAG1 (5 μg/ml; SC-6011; Santa Cruz Biotechnology); β-tubulin IV (5 μg/ml; MU178-UC; Biogenex, Fremont, CA); KRT5 (2 μg/ml; PA1-37974; ThermoFisher Scientific); and SCGB1A1 (5 μg/ml; RD181022220; BioVendor LLC, C a n d l e r, N C ) . I s o t y p e m a t c h e d I g G ( J a c k s o n Immunoresearch Laboratories, West Grove, PA) was the negative control. To visualize the antibody binding, Alexa Fluor® 555 Donkey Anti-Goat IgG (A-21432; Invitrogen) and Alexa Fluor® 546 Goat Anti-Rabbit IgG (A-11035; Invitrogen) labeled secondary antibodies were used. The cells were counterstained with DAPI to identify cell nuclei.
Generation of Lentiviruses
For over-expression of JAG1, the full-length cDNA sequence was PCR amplified using specific primers and cloned into the multiple cloning site of pCDH-MSCV-MCS-EF1α-GFP (CD711B-1, System Biosciences, Mountain View, CA) via EcoRI and BamHI restriction sites. Knockdown of JAG1 expression was performed using the GIPz lentiviral plasmid expressing GFP and either control scrambled or JAG1 specific shRNAmir (shRNA1 RHS4430-99294390 and shRNA2 RHS4430-101073041, GE Dharmacon, Lafayette, CO). For expression of CherryPicker, the pLVX-CherryPicker Control plasmid was used (632580, Clontech Laboratories, Mountain View, CA). Recombinant replication deficient lentiviruses pseudotyped with the VSVg envelope were generated in 293A cells and titered as previously described [39] . BCi-NS1.1 cells were infected with recombinant lentiviruses at an equal multiplicity of infection (MOI = 5) overnight in BEGM supplemented with 2 μg/ml of polybrene. The following day the infectious media was removed and the cells expanded in BEGM to generate sufficient numbers before culturing on ALI as described above.
Isolation of CherryPicker-Positive Cells
For isolation of CherryPicker expressing cells, the CherryPicker Assay Kit was used (632570, Clontech Laboratories). ALI day 28 co-cultures were trypsinized for 6 min to remove the cells from the trans-well insert and generate single cell suspensions. Following neutralization, the cells were centrifuged in a 15 ml tube (23°C, 8 min, 250×g) and washed once with PBS. The cells (5 × 10 5 ) were then incubated with 10 μl of CherryPicker antibody (0.5 mg/ml) in a 1.5 ml tube for 30 min, 23°C with gentle inversion to mix the cells every 10 min. The cells were then washed twice with PBS (23°C, 8 min, 250×g following each wash) and resuspended in 1000 μl of Wash Buffer (1×) provided in the kit. Next, pre-washed magnetic beads (20 μl per 5 × 10 5 cells) were added to each cell suspension followed by incubation for 30 min, 23°C with rotation. Once completed, the tubes were placed on the magnetic stand until the cells were pulled to the wall of the tube to allow removal of the supernatant. The cells were then resuspended with 1000 μl of Wash Buffer (1×) and incubated for 5 min, 23°C with rotation followed by application to the magnetic stand to repeat the wash process. The cells were washed a total of five times and then processed to isolate RNA and generate cyto-preparations to confirm purity.
Statistical Analysis
Statistical comparisons were calculated using an unpaired, 2-tailed Student's t test with unequal variance. A p value < 0.05 was considered significant.
Results
Expression of Notch Signaling Pathway Ligands in Human Airway Basal Cells
Expression of each Notch ligand (DLL1, DLL3, DLL4, JAG1 and JAG2) was analyzed by RNA sequencing in primary BC and hTERT immortalized BC (BCi-NS1.1 cells) [40] . Both primary BC and the BCi-NS1.1 cells expressed the Notch ligands DLL1, JAG1 and JAG2 at comparable levels (Fig. 1a) . The ligands DLL3 and DLL4 were not expressed. In both primary BC and the BCi-NS1.1 cells, JAG1 was the highest expressed ligand. Western analysis demonstrated equal levels of JAG1 protein in primary BC and BCi-NS1.1 cells (Fig. 1b) . Based on the observation that JAG1 was the highest expressed Notch ligand in BC we focused our study on investigating its role in regulating BC differentiation. Analysis of JAG1 expression levels during differentiation of BC on air-liquid interface (ALI) culture demonstrated a significant decrease in expression at ALI day 28 compared to day 0 for both primary BC (0.1-fold, p < 0.001) and BCi-NS1.1 cells (0.5-fold, p < 0.02; Fig. 1c) . Immunofluorescence staining of JAG1 protein at ALI day 28 for both primary and immortalized BC demonstrated strong staining of JAG1 in BC and reduced staining in the luminal differentiated cell populations (Fig. 1d, e) . Together, these data suggest that expression of JAG1 is enriched in BC and there is downregulation of JAG1 expression in differentiated cells. Based on the knowledge that BCi-NS1.1 cells retain the stem/progenitor phenotype of primary BC and have comparable JAG1 expression levels and kinetics, we used BCi-NS1.1 cells as a model to further study the role of JAG1 in regulating Notch dependent differentiation of BC into a mucociliated epithelium.
Modulation of JAG1 Expression Levels During Basal Cell Differentiation
To investigate the effect of modulating JAG1 expression levels on BC differentiation, BCi-NS1.1 cells were infected with either lentivirus expressing GFP (control) or lentivirus expressing GFP and JAG1 (JAG1) for subsequent culture on ALI. To verify over-expression of JAG1, Western analysis was performed on cell lysates of uninfected BCi-NS1.1 cells or cells infected with control or JAG1 lentivirus (Fig. 1f) . Equal infectivity of each virus was confirmed by GFP positivity of the cultures (Fig. 1g) . At ALI day 28, the cells were harvested to confirm that over-expression of JAG1 mRNA was maintained in cells infected with JAG1 lentivirus vs control (3.6-fold, p < 0.005; Fig. 1h ). Based on the knowledge that activation of Notch signaling results in multiple downstream responses in human airway BC [38, 39] , we analyzed the changes in expression of multiple Notch downstream effectors in differentiating BC following over-expression of JAG1. The results demonstrated no significant changes in expression of HES1 (1.1-fold), HES2 (1.1-fold), HES4 (1.1-fold) and HES5 (1.6-fold) in cells over-expressing JAG1 vs control (all p > 0.2, Fig. 1h ). However, there were significant changes in expression of HES6 (0.6-fold), HEY1 (1.9-fold), HEY2 (2.7-fold) and HEYL (2.4-fold) demonstrating increased Notch signaling activity in response to JAG1 over-expression (all p < 0.05; Fig. 1h ).
The effects of JAG1 over-expression on the differentiation capacity of BC into ciliated cells and secretory cells was assessed at the histological level by immunofluorescence staining of ciliated cells and Alcian blue staining for mucus producing secretory cells (Fig. 2a, b) . Both control and JAG1 over-expressing cells differentiated into a mucociliated epithelium, however over-expression of JAG1 resulted in a significant increase in the number of secretory cells (3.4 % control vs 8.0 % JAG1, p < 0.03) with no significant effect on the number of ciliated cells (6.3 % control vs 5.3 % JAG1, p > 0.5, Fig. 2c ). To further characterize the effects of JAG1 overexpression on BC differentiation, the expression of cell typespecific markers was analyzed (Fig. 2d) . Relative to control cells, JAG1 over-expression resulted in a significant decrease in expression of the BC markers KRT5 and TP63 (both 0.7-fold; p < 0.05). Immunofluorescence staining of KRT5 demonstrated a significant decrease in the number of KRT5 positive cells in response to JAG1 over-expression (61.7 % control vs 57.4 % JAG1, p < 0.04) consistent with the mRNA data (Fig. 2d, e, g ). Similarly, consistent with the Alcian blue staining, JAG1 over-expression resulted in a significant increase in expression of the mucus producing secretory cell marker In addition, significant increased expression of the non-mucus producing secretory cell marker SCGB1A1 was also observed in JAG1 over-expressing cells (13.7-fold, p < 0.05) which was further validated at the histological level with increased numbers of SCGB1A1 positive cells (8.2 % control vs 16.6 % JAG1, p < 0.005; Fig. 2d, f, h ). No significant change in expression of the ciliated cell markers DNAI1 and TEKT1 (both 0.8-fold, both p > 0.1) was observed, further confirming the histological data (Fig. 2a, c) .
Together, these data demonstrate that JAG1-dependent Notch activation specifically promotes differentiation of BC into secretory cells.
To further confirm the role of JAG1 mediated Notch signaling on BC differentiation, we assessed the effect of JAG1 knockdown. BCi-NS1.1 cells were infected with either lentivirus expressing GFP and scrambled shRNA (control shRNA) or lentivirus expressing GFP and two different JAG1 specific shRNA (JAG1 shRNA 1 and 2), and the modified cells then cultured on ALI. Knockdown of JAG1 at the protein levels for both JAG1 specific shRNA was confirmed by Western analysis (Fig. 3a) and equal infectivity of each virus was confirmed by GFP positivity of the cultures (Fig. 3b) . Due to loss of shRNA-mediated JAG1 silencing following long term ALI culture (data not shown), the cells were harvested at ALI day 14 to assess the impact of JAG1 knockdown on BC differentiation. TaqMan analysis confirmed knockdown of JAG1 at the mRNA level was maintained at ALI day 14 in cells infected with both JAG1 specific shRNA vs control shRNA lentivirus (both 0.5-fold, p < 0.05; Fig. 3c ). To further characterize the effects of JAG1 knockdown on BC differentiation, the expression of cell type-specific markers was analyzed (Fig. 3c) . Relative to control shRNA cells, JAG1 knockdown with both shRNA resulted in a significant decrease in expression of the secretory cell markers MUC5AC (0.1-fold, p < 0.006 for both shRNA) and SCGB1A1 (0.8-fold shRNA 1 and 0.4-fold shRNA 2; both p < 0.05). Apart from a significant decrease in expression of the BC marker KRT5 (0.7-fold, p < 0.03) in JAG1 shRNA 2 expressing cells relative to control, no significant (all p > 0.1) difference was observed in expression of the BC marker TP63 (0.8-fold shRNA 1 and 0.7-fold shRNA 2) and ciliated cell markers DNAI1 (0.6-fold shRNA 1 and 1.4-fold shRNA 2) and TEKT1 (0.6-fold shRNA 1 and 1.4-fold shRNA 2, Fig. 3c ). Overall, these data demonstrate that JAG1-dependent Notch signaling specifically regulates differentiation of BC into secretory cells with no significant effect on differentiation into ciliated cells.
JAG1-Mediated Intercellular Signaling
The Notch signaling pathway is known to act through direct cell to cell interactions, and thus we assessed whether overexpression of JAG1 in BC could activate Notch signaling in neighboring cells and induce secretory cell differentiation. To answer this question BCi-NS1.1 cells were infected with a lentivirus expressing the chimeric membrane-anchored CherryPicker fluorescent protein which could then can be captured on magnetic beads via a specific antibody. CherryPicker + BCi-NS1.1 cells were subsequently cocultured on ALI with either GFP + control or JAG1 overexpressing BCi-NS1.1 cells at a ratio of 4:1 (GFP:mCherry) for 28 days (Fig. 4a) . At ALI day 28, the cells were harvested and the CherryPicker + cells isolated by magnetic bead separation from each co-culture with purity of the isolated CherryPicker + cells confirmed by fluorescent microscopy which demonstrated the presence of only mCherry + cells and absence of GFP + cells (Fig. 4b) . Following isolation, the differentiation of the mCherry + BC in response to co-culture with control or JAG1 over-expressing cells was assessed by analyzing expression of cell type specific markers. Relative to co-culture with control cells, CherryPicker + cells co-cultured with JAG1 over-expressing cells had a significant decrease in expression of the BC marker TP63 (0.7-fold, p < 0.03) and an increase in expression of the secretory cell markers MUC5AC and SCGB1A1 (2.8-fold and 3.8-fold, respectively; both p < 0.01). No significant changes in expression of the BC (Fig. 4c ). These data demonstrate that over-expression of JAG1 in BC can activate Notch signaling in neighboring BC and promote differentiation into secretory cells.
Discussion
Basal cells (BC) function as stem/progenitor cells of the human airway epithelium that differentiate into secretory and ciliated cells to replenish the airway epithelium during normal turnover and repair [4] [5] [6] [7] [8] [9] [10] [11] . Based on the knowledge the Notch signaling pathway is expressed in the human airway epithelium and Notch signaling activity plays a central role in regulating BC differentiation into secretory and ciliated cells [24, 27-30, 32, 38, 39, 42] , the present study was designed to understand the role of individual Notch ligands in regulating BC differentiation into a mucociliated epithelium. The data demonstrate that expression of JAG1 is highly enriched in BC and that its expression decreases in the differentiated cell populations of the mucociliated epithelium. Furthermore, modulation of its expression levels in BC plays an important role in regulating secretory cell differentiation and BC expressed These are the first studies identifying a role for JAG1 in regulating human airway BC differentiation. Recent studies in murine BC have demonstrated that JAG ligands play an important role in regulating differentiation of the airway epithelium [24, 27] . For example, Mori et al. [24] demonstrated JAG1 and 2 ligands regulate differentiation of BC by generating undifferentiated airway progenitors in a NOTCH3-dependent manner that become terminally differentiated into secretory or ciliated cells in response to a secondary Notch activation signal. In addition, PardoSaganta et al. [27] has shown that BC serve as a niche for their daughter cells by providing a continuous supply of the JAG2 ligand to maintain the secretory cell progenitor pool. Taken together, our data suggests a model whereby JAG1 expression in human airway BC provides a ligand stimulus to activate Notch signaling in other BC to promote secretory cell differentiation, with high levels of JAG1 expression increasing secretory cell differentiation and low levels of JAG1 decreasing secretory cell differentiation. Based on our prior studies demonstrating that constitutive activation of NOTCH1 and NOTCH3 signaling increases secretory cell differentiation of primary basal cells [39] we hypothesize that either one or both of these receptors are engaged by JAG1 on the neighboring cell to increase secretory cell differentiation.
Interestingly, our data demonstrated that modulation of JAG1 expression levels in BC had no impact on ciliated cell differentiation, suggesting that JAG1 specifically regulates secretory cell differentiation of the human airway epithelium. In conjunction with a study demonstrating miRNA-mediated repression of DLL1-NOTCH1 signaling is required for differentiation of human airway epithelial cells into ciliated cells [43] , we hypothesize that Notch-dependent differentiation of the human airway into secretory and ciliated cells is regulated by a distinct set of ligands. Treatment of adult mice with specific therapeutic antibodies that block JAG1-mediated Notch signaling decreased the number of SCGB1A1 + secretory cells in the airway epithelium under homeostatic conditions and reversed goblet cell metaplasia in ovalbumin challenged mice [44] . Therefore, in conjunction with our data, the blockade of JAG1-mediated Notch signaling may be a viable therapeutic strategy to specifically modulate levels of secretory cells in human airway disorders.
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